SCHEMBL2352219

SCHEMBL2352219

Cc1ccc(NC(=O)C2CC2)cc1-c1ccc(C(=O)Nc2ccc(CN3CCCCC3)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 6/20 0.64
▸ MAPK14 Q16539 9/20 0.61
▸ LCK P06239 4/20 0.56
▸ CSF1R P07333 4/20 0.56
▸ TNF P01375 1/20 0.55
▸ EGFR P00533 1/20 0.54
▸ KDR P35968 1/20 0.54
▸ ERBB4 Q15303 1/20 0.54
▸ LMNA P02545 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ RAF1 P04049 1/20 0.51
▸ HSPB1 P04792 1/20 0.51
▸ LYN P07948 1/20 0.51
▸ HTR2C P28335 1/20 0.51
▸ MCHR1 Q99705 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2347964 0.99 ABL1 (0.65) ABL1MAPK14LCKCSF1RTNF
SCHEMBL2346102 0.97 MAPK14 (0.65) ABL1MAPK14LCKCSF1RTNF
SCHEMBL14344806 0.91 ABL1 (0.62) ABL1MAPK14LCKCSF1REGFR
SCHEMBL2346300 0.90 MAPK14 (0.61) ABL1MAPK14LMNA
SCHEMBL12459047 0.90 ALDH1A1 (0.65) ABL1MAPK14LCKCSF1REGFR
SCHEMBL3919974 0.89 ABL1 (0.63) ABL1MAPK14LCKCSF1REGFR
SCHEMBL3917456 0.86 ABL1 (0.59) ABL1MAPK14LCKCSF1REGFR
SCHEMBL2349949 0.85 MAPK14 (0.57) ABL1MAPK14RAF1HSPB1LYN
SCHEMBL3915262 0.85 ABL1 (0.59) ABL1MAPK14LCKCSF1REGFR
SCHEMBL2346742 0.85 ABL1 (0.59) ABL1MAPK14LCKCSF1REGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008303-B2 e.g. 6-Methyl-biphenyl-3,4'-dicarboxylic acid 4'-[(3-bromo-phenyl)-amide]-[(4 morpholin-4-yl-phenyl)-amide]; viricide; with other active viricide such as interferon or ribavirin ASTRAZENECA AB (SE) 2011-08-30 — — US disclosed
Send feedback